Z2001

Zonisamide sodium salt

≥98% (HPLC), powder

• 동의어(들): 1,2-Benzisoxazole-3-methanesulfonamide sodium-potassium salt, Aleviatin sodium-potassium salt, Exceglan sodium-potassium salt, Excegram sodium-potassium salt
• 실험식(Hill 표기법): C₈H₇N₂NaO₃S
• CAS Number: 68291-98-5
• Molecular Weight: 234.21
• MDL number: MFCD01744844
• UNSPSC 코드: 12352200
• PubChem Substance ID: 24278783
• NACRES: NA.77

속성

• Quality Level: 100
• 분석: ≥98% (HPLC)
• 양식: powder
• 색상: white to beige
• solubility: H₂O: >5 mg/mL
• 주관자: Eisai
• SMILES string: [Na]NS(=O)(=O)Cc1noc2ccccc12
• InChI: 1S/C8H7N2O3S.Na/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7;/h1-4H,5H2,(H-,9,11,12);/q-1;+1
• InChI key: ZVBIRPKGWOVBLG-UHFFFAOYSA-N
• 유전자 정보: human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

설명

생화학적/생리학적 작용

Zonisamide sodium salt is an anti-epileptic and also scavenges nitric oxide (NO).

Zonisamide sodium salt is an anti-epileptic. It is effective in various animal epilepsy models and humans with both partial and generalized epileptic seizures. Zonisamide sodium salt also scavenges nitric oxide (NO).

특징 및 장점

This compound was developed by Eisai. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H302
• 예방조치 성명서: P264 - P270 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable
• 개인 보호 장비: dust mask type N95 (US), Eyeshields, Gloves